Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001772:Blood Cell Count; D001792:Blood Platelets; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D004285:Dogs; D006084:Graft Rejection; D006086:Graft vs Host Disease / Q000628:therapy*; D006648:Histocompatibility; D017708:Leukocyte Transfusion; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use*; D011817:Rabbits / Q000276:immunology; D011828:Radiation Chimera; D016038:Skin Transplantation; D013950:Thymus Gland / Q000166:cytology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D011241:Prednisone; D008727:Methotrexate